Wholesalers & distributors
Availability, handling and the work of resolving an exception affect the organisations waiting for medicines.
In development · Intended scope and questions for evaluation
The organisation.
The people around it.
A shortage response can move work and cost from one organisation to another. An evaluation should examine those effects and the limits of the available supply evidence.
The people involved
Licensed wholesalers and distributors, logistics teams, quality functions and the provider or pharmacy teams they serve.
The dependencies
Manufacturers, quality and responsible-person functions, procurement, logistics, hospitals, pharmacies and homecare providers.
What to examine
Exception resolution, lead-time assumptions, continuity, rework, handling requirements and the full cost of the proposed change.
An illustrative set of programme relationships. The actual participants, authority, funding and permissions must be established for the defined setting. Explore every organisation perspective.
The decision worth examining.
Which supply or exception-management question can be examined with permitted records and an accountable operational owner?
A shortage response can move work and cost from one organisation to another. An evaluation should examine those effects and the limits of the available supply evidence.
Develop the programme around the setting.
Begin with the local need, relevant evidence, existing work and an agreed comparison. A proposed programme needs clear activities, alternatives, resources and reasons to revise or reject it.
Exception resolution, lead-time assumptions, continuity, rework, handling requirements and the full cost of the proposed change.
Give each participant a workable role.
Manufacturers, quality and responsible-person functions, procurement, logistics, hospitals, pharmacies and homecare providers.
The overall case and the position of each necessary participant deserve separate examination. Staff time, cash timing, capacity, access, commitments and full costs can change which arrangement is practical.
Make the evaluation useful to a decision.
Identify an accountable sponsor, the current process, the permitted information and what a worthwhile finding would allow the organisation to decide. Include preparation, checking, correction, implementation and support in the comparison.
PHARMORIS is in development. This page describes intended scope and a possible evaluation conversation; it does not establish customers, operational deployment, clinical validation or realised benefit.
Bring the question
your organisation
needs to move.
Tell us where the programme gets stuck, who is affected and what a worthwhile evaluation would help you decide.
Discuss a PHARMORIS evaluationAn initial conversation should describe the organisational question. Agree the purpose and information requirements before sharing records.